Nanostring Technologies, Inc.

Nanostring Technologies, Inc. is a publicly traded provider of advanced genomic analysis platforms and life science tools for translational research and molecular diagnostics. The company specializes in developing and manufacturing technologies such as the nCounter Analysis Systems and GeoMx Digital Spatial Profiler, which enable multiplexed, digital detection and counting of nucleic acids, proteins, and cells. Through federal contract awards, Nanostring supplies specialized laboratory equipment, reagents, assays, and testing services to support genomic, molecular, and cellular analysis for biomedical research and healthcare programs across various government agencies. Their products and services are utilized by researchers and clinicians to gain deeper insights into complex biological systems and diseases.

Nanostring has provided a wide range of goods and services through past prime and sub federal contract awards. These include delivering nCounter and GeoMx analysis systems, custom codesets, reagent kits, and consumables to agencies such as the National Institutes of Health, Department of Veterans Affairs, Department of Agriculture, Department of Defense, and U.S. Geological Survey. Specific products supplied include GeoMx Digital Spatial Profilers, nCounter MAX systems, preventive maintenance services, RNA consumables, and custom gene expression panels. Nanostring has also provided research support services, including spatial transcriptomics analysis and COVID-19 related research using their proprietary technologies. Notable awards include a $496,250 purchase order from the National Institute of Allergy and Infectious Diseases for additional GeoMx and nCounter systems, a $366,500 order from the VA for a GeoMx DSP Instrument and related kits, and multiple awards in the $10,000-$25,000 range for various reagents and consumables. Many of these awards were made without set-aside designations, though some were set aside for small businesses.

Nanostring Technologies holds two significant federal contract IDVs. The first is a single-award indefinite delivery/indefinite quantity contract with the USDA Agricultural Research Service, valued at $596,881.45 over five years through April 2028. Under this vehicle, Nanostring has received multiple delivery orders to supply proprietary codesets and equipment for genomic analysis platforms to support USDA research initiatives. Notable task orders include $131,144 for codesets for the Sprint NanoProfiler and $36,624 for cartridges, reagents, and sample kits. The second IDV is a $2.8 million single-award blanket purchase agreement with the Defense Health Agency, running through August 2026. This agreement allows for the procurement of custom and commercial assays, panels, and consumable reagents compatible with Nanostring's nCounter Analysis Systems. The U.S. Army Research Institute of Infectious Diseases has utilized this agreement to support ongoing diagnostics, vaccines, and therapeutics research programs, with one notable task order for $192,000 worth of XT_GX CODESET products and services.